These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7302902)

  • 21. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
    Aguilar-Salinas CA; Fanghänel-Salmón G; Meza E; Montes J; Gulías-Herrero A; Sánchez L; Monterrubio-Flores EA; González-Valdez H; Gómez Pérez FJ
    Metabolism; 2001 Jun; 50(6):729-33. PubMed ID: 11398153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hyperlipidemia and arteriosclerosis. Prebetalipoproteinemia (based on 70 patients and 20 controls)].
    Loeper J; Rouffy J
    Rev Atheroscler (Paris); 1968; 10(3):30-43. PubMed ID: 5746500
    [No Abstract]   [Full Text] [Related]  

  • 23. [Serum cholesterol in endogenous hyperlipidemia (type IV)].
    Wille LE
    Tidsskr Nor Laegeforen; 1972 Nov; 92(31):2089-92. PubMed ID: 4656549
    [No Abstract]   [Full Text] [Related]  

  • 24. Significance of plasma fibrinopeptide A (fpA) in patients with malignancy.
    Peuscher FW; Cleton FJ; Armstrong L; Stoepman-van Dalen EA; van Mourik JA; van Aken WG
    J Lab Clin Med; 1980 Jul; 96(1):5-14. PubMed ID: 7391657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered sedimentation behavior and ultrastructure of platelets in hyperlipidemia.
    Saleh JW; Hashim SA
    Circulation; 1974 Nov; 50(5):880-6. PubMed ID: 4371995
    [No Abstract]   [Full Text] [Related]  

  • 26. Isolation and characterization of the thrombin-like enzyme from Cryptelytrops purpureomaculatus venom.
    Tan NH
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan; 151(1):131-6. PubMed ID: 19770070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinopeptide A in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism.
    Joist JH
    Clin Lab Med; 1984 Jun; 4(2):363-80. PubMed ID: 6499399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of triglyceride levels to thrombosis in patients with coronary artery disease.
    Zajtchuk R; Zajtchuk J
    Ann Thorac Surg; 1983 Mar; 35(3):274-6. PubMed ID: 6830362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical treatment of hyperlipidemia. 3. Clinical status of the partial ileal bypass operation.
    Buchwald H; Moore RB; Varco RL
    Circulation; 1974 May; 49(5 Suppl):I22-37. PubMed ID: 4596501
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence for abnormalities in clotting and thrombolysis as a risk factor for stroke.
    Pilgeram LO; Chee AN; Von dem Bussche G
    Stroke; 1973; 4(4):643-57. PubMed ID: 4723694
    [No Abstract]   [Full Text] [Related]  

  • 31. [Biological properties of fibrinogen degradation products by thrombin].
    Buczko W
    Pol Tyg Lek; 1981 Jun; 36(23):855-6. PubMed ID: 7024948
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of extravascular clotting on fibrinopeptide A levels in blood.
    Wilner GD; Chatpar P; Te A; Horowitz J
    J Lab Clin Med; 1978 Feb; 91(2):205-13. PubMed ID: 621423
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
    Espinosa RA; Rodríguez-Roa E; Nagy E; Mijares ME; Rodríguez-Larralde A; Gil A; Lundberg U; Carvajal Z; Castillo L; Arocha-Piñango CL
    Invest Clin; 2006 Mar; 47(1):35-48. PubMed ID: 16562643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased cerebral CO(2) reactivity after heparin-mediated extracorporal LDL precipitation (HELP) in patients with coronary heart disease and hyperlipidemia.
    Pfefferkorn TK; Knüppel HP; Jaeger BR; Thiery J; Hamann GF
    Stroke; 1999 Sep; 30(9):1802-6. PubMed ID: 10471427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on the relationship between serum cholesterol and plasma fibrinogen].
    Suschke J; Foldenauer A
    Dtsch Med Wochenschr; 1968 Sep; 93(36):1705-7. PubMed ID: 5668263
    [No Abstract]   [Full Text] [Related]  

  • 36. Questions -and answers- on hyperlipidemia.
    Grundy SM
    Geriatrics; 1981 Sep; 36(9):101-5, 108. PubMed ID: 7274673
    [No Abstract]   [Full Text] [Related]  

  • 37. Impaired fibrinolytic response to exercise in patients with type-IV hyperlipoproteinaemia.
    Epstein SE; Brakman P; Rosing DR; Redwood DR
    Lancet; 1970 Sep; 2(7674):631-4. PubMed ID: 4195770
    [No Abstract]   [Full Text] [Related]  

  • 38. Fibrinopeptide A and sudden coronary death.
    Meade TW; Howarth DJ; Stirling Y; Welch TP; Crompton MR
    Lancet; 1984 Sep; 2(8403):607-9. PubMed ID: 6147643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on hyperlipidemia among Japanese.
    Goto Y; Nakamura H
    Isr J Med Sci; 1969; 5(4):661-5. PubMed ID: 5820494
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of seasonal factors on blood lipid levels and some blood coagulation indices in patients with arteriosclerosis and essential hyperlipidemia].
    Krivoruchenko IV
    Kardiologiia; 1970 Oct; 10(10):35-41. PubMed ID: 5504114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.